The Supreme Court justices indicated they are unlikely to hold generic pharmaceutical manufacturers liable for pharmacists' decisions to prescribe their products in ways that infringe on patents. This protects developers and tech professionals from being held responsible for the actions of third parties beyond their control, ensuring legal clarity and reducing potential liabilities. Watch for a unanimous decision affirming this stance.
Read the full article at SCOTUSblog
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



